Package 71209-104-05

{"route": ["ORAL"], "spl_id": "6c16c48d-a47f-467e-9717-31a7de738b1e", "openfda": {"upc": ["0371209047050"], "unii": ["V3888OEY5R"], "rxcui": ["897640", "897649", "897659"], "spl_set_id": ["5501208c-aa2b-47aa-89f7-87f4d4a73fd0"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-104-05)", "package_ndc": "71209-104-05", "marketing_start_date": "20211227"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-104-10)", "package_ndc": "71209-104-10", "marketing_start_date": "20211227"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "71209-104_6c16c48d-a47f-467e-9717-31a7de738b1e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71209-104", "generic_name": "verapamil hydrochloride", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20170527", "listing_expiration_date": "20261231"}